XBiotech
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $2,620 |
Gross Profit | -435 | -432 | ||
EBITDA | -9,906 | -4,364 | -14,531 | -10,421 |
EBIT | -10,345 | -4,803 | -14,966 | -10,853 |
Net Income | -10,508 | -5,015 | -13,006 | -10,002 |
Net Change In Cash | 0 | 0 | 0 | 2,620 |
Free Cash Flow | -6,624 | -6,183 | -12,003 | -7,457 |
Cash | 172,677 | 183,118 | 188,530 | 201,039 |
Basic Shares | 30,460 | 30,472 | 30,456 | 30,443 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $300 | $4,010 | $18,394 |
Gross Profit | -1,744 | 3,359 | 12,574 | |
EBITDA | -42,471 | -35,766 | -31,876 | -22,434 |
EBIT | -39,370 | -37,510 | -34,490 | -25,082 |
Net Income | -38,531 | -24,557 | -32,900 | -17,414 |
Net Change In Cash | 0 | 300 | 4,010 | 18,394 |
Cost of Revenue | -78,716 | -1,088 | ||
Free Cash Flow | -32,267 | -19,087 | -15,409 | 65,920 |
Cash | 172,677 | 200,023 | 157,306 | 236,983 |
Basic Shares | 30,460 | 30,438 | 30,439 | 30,043 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.34 |
2024-09-30 | -$0.16 |
2024-06-30 | -$0.42 |
2024-03-31 | -$0.32 |
